| Texto completo | |
| Autor(es): |
Pereira, Nathalia de Sousa
;
Vitiello, Glauco Akelinghton Freire
;
Amarante, Marla Karine
Número total de Autores: 3
|
| Tipo de documento: | Artigo Científico |
| Fonte: | DIAGNOSTICS; v. 13, n. 6, p. 12-pg., 2023-03-01. |
| Resumo | |
The association between mouse mammary tumor virus (MMTV)-like sequences and human breast cancer (BC) is largely documented in the literature, but further research is needed to determine how they influence carcinogenesis. APOBEC3 cytidine deaminases are viral restriction factors that have been implicated in cancer mutagenesis, and a germline deletion that results in the fusion of the APOBEC3A coding region with the APOBEC3B 3 '-UTR has been linked to increased mutagenic potential, enhanced risk of BC development, and poor prognosis. However, little is known about factors influencing APOBEC3 family activation in cancer. Thus, we hypothesized that MMTV infection and APOBEC3-mediated mutagenesis may be linked in the pathogenesis of BC. We investigated APOBEC3A/B genotyping, MMTV-like positivity, and clinicopathological parameters of 209 BC patients. We show evidence for active APOBEC3-mediated mutagenesis in human-derived MMTV sequences and comparatively investigate the impact of APOBEC3A/B germline deletion in MMTV-like env positive and negative BC in a Brazilian cohort. In MMTV-like negative samples, APOBEC3A/B deletion was negatively correlated with tumor stage while being positively correlated with estrogen receptor expression. Although APOBEC3A/B was not associated with MMTV-like positivity, samples carrying both MMTV-like positivity and APOBEC3A/B deletion had the lowest age-at-diagnosis of all study groups, with all patients being less than 50 years old. These results indicate that APOBEC3 mutagenesis is active against MMTV-like sequences, and that APOBEC3A/B deletion might act along with the MMTV-like presence to predispose people to early-onset BC. (AU) | |
| Processo FAPESP: | 20/10299-7 - PIWIL4 como regulador epigenético central de elementos retrovirais endógenos no Câncer Gástrico: implicações na imunopatogênese e imunoterapia da doença? |
| Beneficiário: | Glauco Akelinghton Freire Vitiello |
| Modalidade de apoio: | Bolsas no Brasil - Pós-Doutorado |